Literature DB >> 3817306

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

M I Harris, W C Hadden, W C Knowler, P H Bennett.   

Abstract

The prevalence of physician-diagnosed diabetes and of undiagnosed diabetes and impaired glucose tolerance (IGT) that meet National Diabetes Data Group (NDDG) and World Health Organization (WHO) criteria have been estimated for the U.S. population aged 20-74 yr from the 1976-1980 National Health and Nutrition Examination Survey. This survey included a demographic/medical history questionnaire administered in the participant's home and a detailed examination composed of a physician's exam, special clinical procedures, other tests, and collection of blood and urine specimens. Survey participants were selected from 1970 census data through a stratified multistage probability sampling scheme. Of 17,390 eligible residents aged 20-74 yr, 15,357 (88.3%) participated in the interview and are the basis for estimates of diagnosed diabetes; 11,858 (68%) participated in the exam. A half sample of 5901 examinees was selected to receive a 75-g oral glucose tolerance test (OGTT) performed in the morning after an overnight 10- to 16-h fast. Of these examinees, valid OGTT data were obtained for 3772 people without a medical history of diabetes, and these are the basis for estimates of undiagnosed diabetes and IGT. The major reasons for incomplete OGTT data were inability of participants to attend the examination center in the morning and lack of adherence to the fasting instructions. Despite the relatively low response rates, evidence is presented that data on both the interviewed sample and those receiving the OGTT, when adjusted for the 1970-1980 census characteristics by age, race, sex, income, and geographic location, are representative of the U.S. population. Extrapolation of these data to the U.S. population aged 20-74 yr indicates a total diabetes prevalence of 6.6% by NDDG criteria, or more than 8 million people with diabetes. The prevalence of undiagnosed diabetes (3.2%) was almost equal to that of previously diagnosed diabetes (3.4%). Total rates of diabetes increased with age, from 2.0% at age 20-44 yr to 17.7% at age 65-74 yr. Rates were approximately equal by sex but were greater in Blacks than in Whites. The prevalence of undiagnosed diabetes by WHO criteria (3.4%) was similar to that by NDDG criteria, but the rate of impaired glucose tolerance (11.2%) was more than twice the NDDG estimate (4.6%). Both obesity and parental history of diabetes were associated with significantly higher rates of diabetes and IGT. Fasting plasma glucose was relatively insensitive to age, but 1-h and 2-h post-75-g glucose values increased significantly with age.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3817306     DOI: 10.2337/diab.36.4.523

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  168 in total

Review 1.  Strength training in the elderly: effects on risk factors for age-related diseases.

Authors:  B F Hurley; S M Roth
Journal:  Sports Med       Date:  2000-10       Impact factor: 11.136

2.  Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National Integrated Projects for Prospective Observation of Non-communicable Diseases and its Trend in the Aged.

Authors:  K Sakata; T Hashimoto; H Ueshima; A Okayama
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Glycated haemoglobin, diabetes, and mortality in men. Maybe disturbance in physiological mechanisms regulating blood glucose is risk factor for cardiovascular death.

Authors:  R J Jarrett
Journal:  BMJ       Date:  2001-04-21

4.  Intentional weight loss and 13-year diabetes incidence in overweight adults.

Authors:  Julie C Will; David F Williamson; Earl S Ford; Eugenia E Calle; Michael J Thun
Journal:  Am J Public Health       Date:  2002-08       Impact factor: 9.308

Review 5.  What should we measure in the diabetic patient and how does this respond to therapy?

Authors:  Desmond G Johnston; Stephen Robinson; Shareen Forbes
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 6.  Percutaneous coronary intervention in diabetics.

Authors:  Juhana Karha; Deepak L Bhatt
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 7.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

8.  Left bundle branch block in type 2 diabetes mellitus: a sign of advanced cardiovascular involvement.

Authors:  Eliscer Guzman; Narpinder Singh; Ijaz A Khan; Andreas P Niarchos; Cherian Verghese; Cesare Saponieri; Harinder K Singh; Ramesh M Gowda; Balendu C Vasavada; Ronny A Cohen
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

9.  Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study.

Authors:  A Rosengren; L Welin; A Tsipogianni; L Wilhelmsen
Journal:  BMJ       Date:  1989-11-04

Review 10.  Rehabilitative considerations for dental implants in the diabetic patient.

Authors:  Preeti Agarwal Katyayan; Manish Katyayan; Rupal J Shah
Journal:  J Indian Prosthodont Soc       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.